http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101986250-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6854 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70535 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-735 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate | 2017-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101986250-B1 |
| titleOfInvention | Fc gamma receptor variant SH2A40 |
| abstract | The present invention relates to polypeptides comprising an Fc gamma receptor variant. The Fc gamma receptor mutant of the present invention can be obtained by optimizing the substitution of some amino acid sequences of the Fc gamma receptor with other amino acid sequences, thereby enhancing the selective binding ability to immunoglobulin, increasing the half-life of the drug, detecting and purifying immunoglobulins, Or for the prevention or treatment of autoimmune diseases. |
| priorityDate | 2017-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 891.